WO2026133152 - SODIUM CHANNEL BLOCKERS
National phase entry is expected:
Publication Number
WO/2026/133152
Publication Date
25.06.2026
International Application No.
PCT/IB2025/062988
International Filing Date
16.12.2025
Title **
[English]
SODIUM CHANNEL BLOCKERS
[French]
BLOQUEURS DE CANAUX SODIQUES
Applicants **
NOVARTIS AG
JOHNSON, Alyssa Miranda
QIAN, Ming
Inventors
DANILACK, Aaron David
HURLEY, Timothy Brian
KING, Sandra
KOENIG, Robert
LAL, Ajay Kumar
LAU, Sii Hong
LU, Jianliang
PATEL, Tajesh Jayprakash
PENG, Yunshan
PETERSON, Emily
Priority Data
63/735,567
18.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3669 | |
| EPO | Filing, Examination, Granting | 20108 | |
| Japan | Filing, Examination, Granting | 2596 | |
| South Korea | Filing, Examination, Granting | 3040 | |
| USA | Filing, Examination, Granting | 8690 |
Total:
38,103
Contact Us
Abstract[English]
The present disclosure relates to sulfonamide compounds, the use thereof for modulat- ing the sodium channel Nav1.5 and methods of treating or preventing diseases, disorders, or conditions using the same.[French]
La présente divulgation concerne des composés sulfonamides, leur utilisation pour moduler le canal sodique Nav1.5 et des méthodes de traitement ou de prévention de maladies, de troubles ou d'affections à l'aide de ceux-ci.